An Experimental Gene Therapy for Gaucher Disease has Earned Orphan Drug Designation
According to a story from pharmanewsdaily.com, the gene therapy company Avrobio has recently announced that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to AVR-RD-02, an…